Doctors 2.0 & You and Expanscience Introduce New Preventive Health Short Video Awards Contest

Doctors 2.0 & You4 - 5 June 2015, Paris, France.
United by their mutual commitment to the preservation of health in people everywhere, Doctors 2.0 & You, the international digital health conference and industry partner, Expanscience, an international pharmaceutical and dermo-cosmetics laboratory, invite videomakers to contribute to health prevention promotion by participating in the First Health Prevention Short Video Contest Awards.

Applicants to the contest are invited to produce a short video (up to 120 seconds) that expresses public health messages on one of the two following themes that will benefit from the expertise of Expanscience.

  • How to preserve skin health in babies, teens, pregnant women, and new moms
  • How to prevent osteoarthritis and other rheumatological diseases

According to Doctors 2.0 & You founder Denise Silber, "A short video is an excellent medium to reach and impact a broad audience. We are very pleased to join forces with Expanscience to encourage the production and distribution of great videos and hope that many people will be inspired to help out."

For Jean-Paul Berthomé, CEO of Expanscience, "A brand has more than one dimension and a company as well. At Expanscience we are not just in the business of pharmaceuticals and dermo-cosmetics. Health and prevention are a priority for us. So, it was very natural for us to enter into partnership with Doctors 2.0 & You and reward two video projects, one in the prevention of osteoarthritis and related conditions and the other for the maintenance of healthy skin. We truly hope people around the world will contribute their ideas."

About the Awards Process

  • Contest submissions are open from April 14th, 2015 to May 19th, 2015.
  • The first prize winner in each category (skin health and rheumatology) will receive an award of 2000 euros.
  • The decision will be made by a jury of 7 persons selected for their experience in healthcare and communication.
  • The winner will be announced during the 5th Edition of Doctors 2.0 & You, on June 5, 2015 at Cité Universitaire Paris, France.
  • Videos that respond to the criteria indicated in the complete contest rules online will be displayed on the Doctors 2.0 & You Facebook page during the contest period and through October 31, 2015. The winning videos will be promoted online more broadly.
  • To apply, contestants must fill in the form on the website and submit their video online at http://www.doctors20.com/contests-2/short-video-contest-2015/

For further information, please visit:
http://www.doctors20.com

About Doctors 2.0 & You
Innovative, Insightful, Inspiring, Doctors 2.0 & You is "the must-attend annual digital health conference in Europe". Taking place in Paris, for its fifth edition, on June 4-5, 2015, Doctors 2.0 & You is the only international congress providing a 360° view of state of the art tools and services linking patients and physicians with all other healthcare stakeholders. The conference was founded by Denise Silber, pioneering digital health strategist and influencer.and president of Basil Strategies.

Attendees include patients, professionals, healthcare industries, technologists, payers, government. Key topics in 2015 will include artificial intelligence, augmented reality, 3d printing, connected objects as well as mobile apps, communities, serious games, with examples of deployment in multiple medical conditions. The hashtag #doctors20 is the most tweeted in its category, with nearly 9000 participants to-date.

About Expanscience
In 2014, Expanscience - a French independently-owned pharmaceutical and dermo-cosmetics laboratory - generated turnover of €269.8 million, 46.1% of which was through exports, and employed 967 people. Over more than 60 years, the company has built up a solid international reputation as an innovator and as a specialist in skin and the treatment of arthritis. Its products, which include two leading brands - Piasclédine 300 and Mustela - are sold in more than 97 countries (84 distributing countries and 13 subsidiaries). Expanscience develops and also sells natural-origin active ingredients for use in cosmetics, both in France and abroad. The whole value chain is integrated into the company - from research through to production and distribution. Its CSR policy, which was introduced 10 years ago, was recognised as exemplary by the AFAQ 26000 assessment in 2013.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...